Dermatofibroma classification: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 2: | Line 2: | ||
{{Dermatofibroma}} | {{Dermatofibroma}} | ||
{{CMG}};{{AE}}{{Homa}} | {{CMG}};{{AE}}{{Homa}} | ||
==Overview== | ==Overview== | ||
There is no established system for the classification of [disease name]. | There is no established system for the classification of [disease name]. | ||
Line 35: | Line 27: | ||
==Classification== | ==Classification== | ||
Dermatofibroma may be classified according to | Dermatofibroma may be classified according to [[histopathology]] into three subtypes: | ||
*Variants that are prominent in architectural (low-power) properties | |||
*Variants that are prominent in [[Cytological|cytologic]] or [[stromal]] (high-power) properties | |||
*Variants that have architectural (low) and [[cytological]] or [[stromal]] (high-power) properties | |||
<br /> | |||
{{familytree/start}} | {{familytree/start}} |
Revision as of 17:33, 14 August 2019
Dermatofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dermatofibroma classification On the Web |
American Roentgen Ray Society Images of Dermatofibroma classification |
Risk calculators and risk factors for Dermatofibroma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is no established system for the classification of [disease name].
Dermatofibroma may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
The staging of [malignancy name] is based on the [staging system].
There is no established system for the staging of [malignancy name].
Classification
Dermatofibroma may be classified according to histopathology into three subtypes:
- Variants that are prominent in architectural (low-power) properties
- Variants that are prominent in cytologic or stromal (high-power) properties
- Variants that have architectural (low) and cytological or stromal (high-power) properties
Histopathology varient of dermatofibroma | |||||||||||||||||||||||||||||||||||||
Variants that are prominent in architectural (low-power) properties | Variants that are prominent in cytologic or stromal (high-power) properties | Variants that have architectural (low) and cytological or stromal (high-power) properties | |||||||||||||||||||||||||||||||||||
1.Deep penetrating dermatofibroma
2. Atrophic dermatofibroma 3. Aneurysmal fibrous histiocytoma 4. Haemangiopericytoma-like fibrous histiocytoma 5. Palisading cutaneous fibrous histiocytoma 6. Lichenoid, erosive, & ulcerated dermatofibroma 7.Plaque-like dermal fibromatosis, dermatofibroma | 1. Clear cell dermatofibroma
2. Granular cell dermatofibroma 3. Myofibroblastic dermatofibroma 4. Sclerotic dermatofibroma 5. Keloidal dermatofibroma 6. Atypical/pseudosarcomatous fibrous histiocytoma, dermatofibroma with monster cells 7. Hemosiderrhotic dermatofibroma 8. Cholesterotic/lipidized dermatofibroma 9. Myxoid dermatofibroma 10. Ossifying dermatofibroma 11. Pseudolymphomatous dermatofibroma 12. Dermatofibroma with diffuse eosinophilic infiltrate | 1. Epithelioid cell histiocytoma
2. Cellular benign fibrous histiocytoma 3. Smooth muscle proliferation in dermatofibroma 4. Multinucleate cell angiohistiocytoma 5. Cellular neurothekeoma 6. Combined DF | |||||||||||||||||||||||||||||||||||